Author:
Ng Terry L.,Narasimhan Narayana,Gupta Neeraj,Venkatakrishnan Karthik,Kerstein David,Camidge D. Ross
Funder
Takeda Pharmaceutical Company
ARIAD
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference19 articles.
1. Alunbrig [package insert]. Cambridge, MA: Takeda Pharmaceutical Company Limited; 2018.
2. Alunbrig Canada [product monograph],2018
3. Alunbrig [summary of product characteristics],2019
4. Brigatinib versus crizotinib in ALK-positive non–small-cell lung cancer;Camidge;N Engl J Med,2018
5. Brigatinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-small-cell lung cancer: a randomized, multicenter phase II trial;Kim;J Clin Oncol,2017
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献